Engineered Heart Tissues for Standard 96-Well Tissue Culture Plates

Alex J Goldstein,Ruby M Padgett,Samantha B Bremner,Ty Higashi,Ava M Obenaus,Sam Bolduan,David L Mack,Nathan J Sniadecki
DOI: https://doi.org/10.1007/978-1-0716-3854-5_5
Abstract:Engineered heart tissues (EHTs) have been shown to be a valuable platform for disease investigation and therapeutic testing by increasing human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) maturity and better recreating the native cardiac environment. The protocol detailed in this chapter describes the generation of miniaturized EHTs (mEHTs) incorporating hiPSC-CMs and human stromal cells in a fibrin hydrogel. This platform utilizes an array of silicone posts designed to fit in a standard 96-well tissue culture plate. Stromal cells and hiPSC-CMs are cast in a fibrin matrix suspended between two silicone posts, forming an mEHT that produces synchronous muscle contractions. The platform presented here has the potential to be used for high throughput characterization and screening of disease phenotypes and novel therapeutics through measurements of the myocardial function, including contractile force and calcium handling, and its compatibility with immunostaining.
What problem does this paper attempt to address?